#results
Latest news and interesting information about results.
BMO Raises Israel Chemicals Target Price on Potash
BMO Capital raises Israel Chemicals price target to $6.50 on strong potash outlook and higher EBITDA guidance.
Cantor Fitzgerald raises PANW price target to $285
Cantor Fitzgerald raises Palo Alto Networks price target to $285, citing platformization, AI tailwinds, and strong partner results.
Rosenblatt Raises 8x8 Target to $3.00
Rosenblatt raises 8x8 stock target to $3.00 after strong Q4 results. Revenue beat guidance.
Rosenblatt Cuts Canaan Target Price to $1.30
Rosenblatt cuts Canaan stock price target to $1.30 from $2.25, maintains Buy rating. Canaan faces revenue miss in Q1 FY2026.
Alpha Tau Stock Gets Buy Rating, $15 Target
H.C. Wainwright reiterates Buy on Alpha Tau stock with $15 target. Company completes ReSTART trial enrollment.
Traws Pharma Gets $8 Price Target from H.C. Wainwright
H.C. Wainwright reaffirms Buy on Traws Pharma with $8 target. Financing secured for influenza drug trial. Read more on Bond.az.
Master's exam results announced
Master's admission exam results announced. Check results for May 17, 2025 exam on SEC website or via 7727.
BTIG Lowers ServiceTitan Target, Keeps Buy
BTIG lowered ServiceTitan price target to $90 from $105, maintains Buy rating. Revenue growth 24.5%, gross margins 70%.
Keefe Bruyette Reiterates Bitdeer Rating on AI Shift
Keefe, Bruyette & Woods reiterates Market Perform rating on Bitdeer stock with $11.50 target amid AI mix shift and Tydal project focus.
Hasbro beats quarterly estimates on digital games demand
Hasbro beats Q1 estimates with strong digital games demand, including Magic: The Gathering. Revenue and profit exceed expectations. Read more on Bond.az.
Perion stock rises 4% on guidance despite miss
Perion Network shares rose 4% after maintaining 2026 guidance despite Q1 revenue miss.
Immunovant stock jumps 20% on RA trial
Immunovant stock jumps 20% after positive rheumatoid arthritis trial data for IMVT-1402.
KeyBanc lowers Karman Holdings stock price target
KeyBanc lowered Karman Holdings price target to $100 from $122. Shares down 46% from highs. Analysts cut earnings forecasts.
Nvidia results could shake markets
Nvidia results could shake markets. Fed minutes and bond yields in focus.
Citizens Upgrades Toll Brothers Rating on Strong Earnings
Citizens upgrades Toll Brothers rating after strong Q2 earnings beat, highlighting price and volume performance.
Baozun Stock Up 4% on Earnings Beat
Baozun stock rises 4% after Q1 earnings beat and return to profit. E-commerce and brand management divisions drive strong results.
Raymond James Keeps Market Perform on CAVA
Raymond James maintains Market Perform rating on CAVA after impressive Q1 earnings with 9.7% comp sales growth and raised guidance.
Stifel raises Cava Group price target to $105
Stifel raises Cava Group price target to $105, citing strong comps and AI investments. Analysts remain bullish on growth.
Jefferies Raises Cava Target to $95 on Strong Sales
Jefferies raises Cava Group price target to $95 from $85, citing strong same-store sales growth and positive momentum. Maintains Buy rating.
Knights stock jumps 6% on growth
Knights Group Holdings shares jumped 6% after reporting strong fiscal 2026 results with 28% revenue growth and accelerating organic growth.
Siemens AG Q2 2026: Strong Results Amid Challenges
Siemens AG Q2 2026 results show resilience with record backlog and strong growth in digital industries and smart infrastructure.
Full Truck Alliance SWOT analysis: stock faces transformation
Full Truck Alliance SWOT analysis: stock faces transformation amid growth concerns. Analyst insights on Bond.az.
British Land posts solid Q2 2026 performance
British Land Company reports strong Q2 2026 results with profit and EPS growth, driven by science and technology sector focus and robust leasing activity.
IntegraFin Falls Despite Profit Beat
IntegraFin shares drop 4.6% despite beating profit forecasts. Pre-tax profit rises 16% YoY to £43.9m.
Why is Experian stock falling?
Experian stock falls 5.2% after earnings release. FY27 guidance disappoints investors. Detailed analysis on Bond.az.
Iran war, Nvidia earnings move markets
Bond.az covers Iran war, Nvidia earnings, SpaceX IPO, and Fed minutes moving markets.
BofA Maintains Buy on MakeMyTrip, $60 Target
BofA Securities reiterates Buy on MakeMyTrip (MMYT) with $60 target due to margin expansion and cost control in Q4 results.
FTSE 100 falls as yields surge, Iran tensions linger
FTSE 100 falls as global bond yields surge and Iran tensions persist. UK inflation softens but PPI rises. Bond.az covers market updates.
European stocks dip on Nvidia, inflation fears
European stocks fell on Wednesday as Nvidia earnings and inflation concerns weigh. Stoxx 600, DAX, CAC 40, FTSE 100 all down.
Molina Healthcare Stock: Under Margin Pressure
Molina Healthcare stock faces margin pressures from rising medical loss ratio and membership attrition. Analysts downgrade outlook; potential off-cycle rate adjustments offer upside.
...